Literature DB >> 28208913

Eosinophilic Granulomatosis with Polyangiitis (EGPA) and Hepatitis B Infection - A Rare Association.

Nidhi Kaeley1, Narula Kamakshi2.   

Abstract

Eosinophilic Granulomatosis with Polyangiitis (EGPA) or Churg-Strauss syndrome is a rare systemic illness which is characterized by necrotizing inflammation of small and medium sized vessels. The prominent features include asthma, eosinophilia, transient pulmonary infiltration and systemic vasculitis. Various triggering factors have been reported as putative aetiological agents of Churg-Strauss syndrome. They include infections, allergic desensitization, vaccinations like hepatitis B and influenza vaccination, cocaine abuse, drugs like leukotriene receptor antagonists and exposure to pigeons. We report a rare case of Churg-Strauss syndrome co-infected with Hepatitis B Virus (HBV). Very few such cases have been reported in the past.

Entities:  

Keywords:  Asthma; Eosinophilia; Necrotizing

Year:  2016        PMID: 28208913      PMCID: PMC5296486          DOI: 10.7860/JCDR/2016/20181.9067

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  12 in total

1.  A case of Churg-Strauss vasculitis after hepatitis B vaccination.

Authors:  M Vanoli; D Gambini; R Scorza
Journal:  Ann Rheum Dis       Date:  1998-04       Impact factor: 19.103

Review 2.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

3.  [Churg-Strauss syndrome and pulmonary fibrosis: an unusual association].

Authors:  Maté Streho; Régis Sable-Fourtassou; Marie Charlotte Brion; Isabelle Bourotte; Dominique Valeyre; Michel Brauner; Robin Dhote; Sébastien Abad
Journal:  Presse Med       Date:  2006-09       Impact factor: 1.228

4.  The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).

Authors:  A T Masi; G G Hunder; J T Lie; B A Michel; D A Bloch; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt
Journal:  Arthritis Rheum       Date:  1990-08

5.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.

Authors:  E C Hagen; M R Daha; J Hermans; K Andrassy; E Csernok; G Gaskin; P Lesavre; J Lüdemann; N Rasmussen; R A Sinico; A Wiik; F J van der Woude
Journal:  Kidney Int       Date:  1998-03       Impact factor: 10.612

Review 6.  Churg-Strauss syndrome.

Authors:  Imre Noth; Mary E Strek; Alan R Leff
Journal:  Lancet       Date:  2003-02-15       Impact factor: 79.321

7.  Churg-strauss syndrome and active chronic hepatitis B virus infection: coincidence or association?

Authors:  Diogo Souza Domiciano; Samuel Katsuyuki Shinjo; Maurício Levy-Neto
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

8.  Cocaine-induced Churg-Strauss vasculitis.

Authors:  R Orriols; X Muñoz; J Ferrer; P Huget; F Morell
Journal:  Eur Respir J       Date:  1996-01       Impact factor: 16.671

Review 9.  Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.

Authors:  J G Lanham; K B Elkon; C D Pusey; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1984-03       Impact factor: 1.889

10.  Churg-Strauss syndrome with perforating ulcers of the colon.

Authors:  Y B Kim; S W Choi; I S Park; J Y Han; Y S Hur; Y C Chu
Journal:  J Korean Med Sci       Date:  2000-10       Impact factor: 2.153

View more
  2 in total

1.  Eosinophilic granulomatosis with polyangiitis is associated with hepatitis B virus infection.

Authors:  Yun Liu; Xiaomin Dai; Zhihui Dong; Yuan Ji; Lili Ma; Huiyong Chen; Lindi Jiang
Journal:  Clin Rheumatol       Date:  2022-04-11       Impact factor: 3.650

2.  HBsAg-negative and anti-HBc-positive in eosinophilic granulomatosis with polyangiitis: a retrospective pilot study.

Authors:  Sang-Won Lee; Do Young Kim; Sang Hoon Ahn; Yong-Beom Park; Kwang-Hyub Han; Jun Yong Park
Journal:  Rheumatol Int       Date:  2018-05-12       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.